|
FY2025
12 months to Jan 30, 2026
|
FY2024
12 months to Jan 31, 2025
|
FY2023
12 months to Feb 2, 2024
|
FY2022
12 months to Feb 3, 2023
|
FY2021
12 months to Jan 28, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Noncash lease expense | |||||
| Deferred income taxes | |||||
| Asset impairment and loss on property - net | |||||
| Gain on sale of business | |||||
| Share-based payment expense | |||||
| Changes in operating assets and liabilities: | |||||
| Merchandise inventory – net | |||||
| Other operating assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Other operating liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investments | |||||
| Proceeds from sale/maturity of investments | |||||
| Capital expenditures | |||||
| Proceeds from sale of property and other long-term assets | |||||
| Acquisition of businesses - net | |||||
| Other – net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in commercial paper | |||||
| Net proceeds from issuance of debt | |||||
| Repayment of debt | |||||
| Proceeds from issuance of common stock under share-based payment plans | |||||
| Cash dividend payments | |||||
| Repurchases of common stock | |||||
| Other – net | |||||
| Net cash provided by/(used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...
